Physician

David A Snyder, MD

According to 2025 Medicare claims, David Snyder, MD (NPI: 1487653176) practices hematology/oncology in the Santa Fe, NM market, with the plurality of this provider's patient population coming from Santa Fe, NM. This provider's primary affiliated billing organization is NEXUS HEALTH (NPI: 1801516489; TIN: 87-3699084) and primary practice location at 87507-9998.

Snyder's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 330 traditional Medicare patients, billed 79,793 HCPCS/CPT codes, and received $1,642,992 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 1,454 prescription claims across 172 beneficiaries totaling $2,843,856 in drug costs, led by Jakafi (Ruxolitinib Phosphate). DME data shows 55 claims. Open Payments data shows 160 records totaling $3,182. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $149,692 to $1,642,992. Similarly, Part D prescription costs have risen steadily, from $933,879 to $2,843,856. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $4,046 and ending at $2,348.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	425	5,873	$149,692
2016	425	4,950	$180,838
2017	414	1,995	$177,287
2018	317	1,601	$151,980
2019	318	1,619	$155,388
2020	352	1,681	$165,748
2021	380	1,819	$198,255
2022	391	1,373	$119,045
2023	336	83,198	$2,092,443
2024	330	79,793	$1,642,992

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	181	1,040	$933,879
2016	188	1,152	$2,022,350
2017	195	1,232	$2,209,514
2018	145	1,054	$2,496,246
2019	146	919	$2,616,231
2020	172	1,240	$3,363,698
2021	171	1,192	$3,269,781
2022	195	1,471	$3,709,816
2023	172	1,398	$3,862,819
2024	172	1,454	$2,843,856

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	57	$31,618
2016	N/R	85	$2,787
2017	N/R	11	$1,292
2018	N/R	28	$1,960
2019	N/R	47	$6,683
2020	N/R	119	$7,640
2021	N/R	12	$171
2022	N/R	30	$1,435
2023	N/R	27	$1,819
2024	N/R	55	$2,760

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	60	60	$154
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	51	236	$137
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	215	582	$92
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	153	222	$61
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	198	522	$13

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Jakafi	Ruxolitinib Phosphate	26	780	$436,426
Xtandi	Enzalutamide	26	780	$332,617
Xalkori	Crizotinib	12	360	$270,499
Iclusig	Ponatinib Hcl	12	360	$256,887
Calquence	Acalabrutinib Maleate	12	360	$185,363

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4419	Ostomy pouch, closed; for use on barrier with non-locking flange, with filter (2 piece), each	N	N/R	11	$1,185
A4414	Ostomy skin barrier, with flange (solid, flexible or accordion), without built-in convexity, 4 x 4 inches or smaller, each	N	N/R	11	$1,052
A4394	Ostomy deodorant, with or without lubricant, for use in ostomy pouch, per fluid ounce	N	N/R	11	$361
A4406	Ostomy skin barrier, pectin-based, paste, per ounce	N	N/R	11	$123
A4371	Ostomy skin barrier, powder, per oz	N	N/R	11	$39

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	160	$3,182	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for David A. Snyder, MD?

Tedicare shows public-source Medicare data for David A. Snyder, MD (NPI 1487653176), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does David A. Snyder, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to David A. Snyder, MD?

David A. Snyder, MD is linked to NEXUS HEALTH (billing NPI 1801516489) in the available physician profile data.

Does David A. Snyder, MD have Open Payments data?

David A. Snyder, MD has 160 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.